A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myeloma (Q33385533)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myeloma |
scientific article |
Statements
1 reference
A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myeloma (English)
1 reference
Alessandro Rambaldi
1 reference
Monica Galli
1 reference
Silvia Salmoiraghi
1 reference
Antonella Gozzini
1 reference
Claudia Crippa
1 reference
Norbert Pescosta
1 reference
25 July 2009
1 reference
1 reference
89
1 reference
185-190
1 reference
Identifiers
1 reference
1 reference